604 results found

This is the first case in China where a court denied the validity of an agreement with a valuation adjustment mechanism.

A foreign-invested commercial enterprise is often the ideal choice for foreign investors who need to source from China or wish to have direct access to its domestic consumer market, businesses, and tenders.

On 3 February 2011 a new circular entitled "Circular of the General Office of the State Council on the Establishment of a Security Review System Regarding Mergers and Acquisition of Domestic Enterprises by Foreign Investors" was published by China’s State Council.

On March 16, 2007, China's 10th National People's Congress enacted a new PRC Enterprise Income Tax Law (EIT Law). When the EIT Law takes effect on January 1, 2008, it will dramatically alter the manner in which China taxes Foreign Invested Enterprises (FIEs). In essence, the new EIT Law will eliminate entirely the preferential tax regime for FIEs.

On March 4, 2011, the Ministry of Commerce of People’s Republic of China ("MOFCOM") issued initial procedural rules to implement the new mechanism, announced on February 3, 2011, by which certain foreign direct investment transactions will be reviewed on national security grounds.

The PRC's foreign exchange reserves experienced a continuous drop during the second half of 2016 and hit the psychological level of US$3 trillion for the first time since February 2011.

New regulations have relaxed restrictions on foreign investments in various value-added telecommunication services.

China's e-commerce sector has recently experienced rapid growth to become the largest e-commerce market in the world.

On December 29, 2023, the Standing Committee of the National People's Congress of the People's Republic of China adopted an amendment to the Company Law, which will come into effect on July 1, 2024.

These are Jiangsu, Shandong, Hebei, Heilongjiang, Guanxi, and Yunnan.

China has rapidly emerged as a dominant force in early-stage biotech innovation, challenging traditional U.S. hubs like San Francisco and Boston through faster development timelines, lower clinical trial costs, and aggressive government support. As deal volume between Western biopharma companies and Chinese biotechs surges dramatically, industry leaders must navigate the complex balance between accessing China's growing scientific contributions and managing heightened geopolitical tensions and U.S. regulato

Summary of some of the key changes to company law in China which will impact international investors.

China’s State Council recently released long-anticipated guidelines, entitled the Notice on the Establishment of the Security Review System for Foreign Mergers and Acquisitions of Domestic Enterprises

For foreign investors who maintain operations in China, or plan to enter the market, figuring out the impact of the new Foreign Investment Law (FIL) on their plans is a business-critical task.

The recently issued Opinions aim to attract foreign investment by further improving the relevant business environment in China. The Opinions propose 24 policy measures in six major areas...

This Catalogue is the central policy that regulates the inflow of foreign investment in various Chinese industries.

2020年《中华人民共和国外商投资法》（以下简称"《外商投资法》"）实施后，取代了原有的"外资三法"，即《中华人民共和国...